Quest Diagnostics Incorporated DGX recently announced that the company is now offering the liquid biopsy-based Target Selector NGS Lung Panel test developed by Biocept BIOC. The addition of this blood ...
Join this webinar to learn how capillary electrophoresis (CE) complements sequencing technologies, such as next generation sequencing, that are being used by cancer researchers today. Additionally, Dr ...
NORTHFIELD, Ill.--(BUSINESS WIRE)--Precision medicine continues to gain momentum from the laboratory benchtop to the patient's bedside, with the CAP leading—as it has for over 10 years—in improving ...
Increasing localized access can provide faster results for patients while potentially improving patient outcomes Agreement aims to enable greater access to localized advanced testing capabilities for ...
Jennifer Gass, PhD, FACMG, associate director, Genetics Laboratory, Florida Cancer Specialists & Research Institute, discusses the recent Genetics Laboratory, which focuses on next-generation ...
To permanently access this eBook for free, fill out the short form below. Ready to revolutionise your molecular testing for myeloid malignancies? With a constantly expanding list of biomarkers, ...
This 9-month investigation looked into the potential for next-generation sequencing (NGS) at the point of care to increase turnaround time for biomarker testing results in advanced colorectal cancer ...
NATICK, Mass., July 30, 2024 /PRNewswire/ -- Pillar Biosciences, Inc., the leader in Decision Medicine(TM), has announced that Molecular Pathology Laboratory Network, Inc., (MPLN) is now the first ...
Thermo Fisher Scientific TMO recently announced a collaboration with Pfizer to increase local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients. The ...
New Working Group to Evaluate Clinical Utility of NGS-Based Testing to Inform Coverage After many years of steady development in DNA sequencing, the scientific community is reaching an exciting ...
Randy Pritchard, Pillar Biosciences CEO, highlighted some of the progress the oncology solutions company has made in developing in-vitro diagnostics, in response to emailed questions from MedCity News ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results